Search

everythinglearnresearchcommunity

for

Search:↓

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Hair loss gene linked to prostate issues.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Longer CAG repeats in gene linked to more severe hair loss in females.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Women with hair loss have more androgen receptors in certain hair follicles.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

New compounds were made that are promising for prostate cancer therapy.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

No clear link between specific gene and hair loss in Mexican brothers.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.